MedPath

Short-course Antimicrobial Therapy in Sepsis

Phase 2
Conditions
Infection
Septic Shock
Sepsis
Severe Sepsis
Interventions
Registration Number
NCT02899143
Lead Sponsor
Ospedale Santa Maria delle Croci
Brief Summary

The purpose of this study is to compare the effect of a short course antimicrobial therapy (5-days) versus a 10-days therapy on sepsis-related organ dysfunction.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
320
Inclusion Criteria
  • Patients who received antibiotics for presumed infection
Exclusion Criteria
  • Prolonged therapy (eg, endocarditis)
  • Severe immunosuppression
  • Severe infections (due to viruses, parasites, or Mycobacterium tuberculosis)
  • Patients previously infected or colonized with multidrug resistant pathogens and moribund patients.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 10-daysAntibiotic10-days targeted antibiotic therapy
Group 5-daysAntibiotic5-days targeted antibiotic therapy
Primary Outcome Measures
NameTimeMethod
sepsis-related organ dysfunction14-days

Score used to track a person's status during the stay in an intensive care unit (ICU) to determine the extent of a person's organ function or rate of failure. The Sequential Organ Failure Assessment (SOFA) score numerically quantifies the number and severity of failed organs. Higher values represent worse outcome. A score of 0 is given for normal function through to 4 for most abnormal. The systems studied are: respiratory, coagulation, hepatic, cardiovascular, central nervous system, and renal.

Secondary Outcome Measures
NameTimeMethod
Hospital mortality30-days

In hospital mortality rate

Trial Locations

Locations (4)

Ospedale Umberto I

🇮🇹

Lugo, Ravenna, Italy

Ospedale Santa Maria Delle Croci

🇮🇹

Ravenna, Italy

Azienda Ospedaliera S.Croce e Carle - Ospedale S.Croce

🇮🇹

Cuneo, Italy

ASST Fatebenefratelli Sacco

🇮🇹

Milano, Italy

© Copyright 2025. All Rights Reserved by MedPath